Clopidogrel vs aspirin monotherapy beyond 1 year after percutaneous coronary intervention

H Watanabe, T Morimoto, M Natsuaki… - Journal of the American …, 2024 - jacc.org
Background It remains unclear whether clopidogrel is better suited than aspirin as the long-
term antiplatelet monotherapy following dual antiplatelet therapy (DAPT) after percutaneous …
被引用次数：4 相关文章

[引用][C] Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

H Watanabe, T Morimoto, M Natsuaki… - Journal of the American …, 2024 - cir.nii.ac.jp
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

H Watanabe, T Morimoto, M Natsuaki, K Yamamoto… - 2024 - pubmed.ncbi.nlm.nih.gov
Background It remains unclear whether clopidogrel is better suited than aspirin as the long-
term antiplatelet monotherapy following dual antiplatelet therapy (DAPT) after percutaneous …

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

H Watanabe, T Morimoto, M Natsuaki… - Journal of the American …, 2024 - Elsevier
Background It remains unclear whether clopidogrel is better suited than aspirin as the long-
term antiplatelet monotherapy following dual antiplatelet therapy (DAPT) after percutaneous …